DailyDoctor Archive Specialties Get app
All internal medicine briefings

The edition · Internal Medicine

First-trimester benzodiazepines showed no rise in major malformations across four million pregnancies

Reassurance on benzodiazepines in early pregnancy, automated oxygen titration that cut hyperoxaemia on the ward, fluvoxamine for long COVID fatigue, and a hospitalist-run rehabilitation unit that shortened discharge waits.

The edition in brief

A US cohort of about 4.2 million pregnancies in Medicaid and commercial insurance data found no increase in major congenital malformations after first-trimester benzodiazepine exposure (pooled RR 0.99, 95% CI 0.96 to 1.03), with no dose-response and similar results across individual drugs; coexposure with other psychoactive drugs gave inconsistent signals. SAVE-O2 AI, a four-hospital randomised trial in 300 acutely ill adults on supplemental oxygen, found that a closed-loop device kept saturations in the 90 to 96% range 85% of the time against 63% with manual titration, mainly by cutting time spent above 96% from 29% to 9%. A Brazilian adaptive trial in 399 adults with long COVID fatigue found fluvoxamine 100 mg twice daily modestly improved fatigue scores at 60 and 90 days compared with placebo; metformin results were inconclusive. A US VA hospitalist-led short-stay rehabilitation unit cut mean referral-to-discharge time from 6.9 to 3.4 days over two years. The pearl covers oxygen targets on the ward.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for internal medicine, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free